Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Apatinib Mesylate in the Treatment of Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

NCT03546855 is registered in ClinicalTrials.gov with Anhui Provincial Hospital as lead sponsor.

NCT NCT03546855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03546855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Apatinib Mesylate in the Treatment of Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Lead sponsor
Anhui Provincial Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2018
Completion date
June 1, 2020
Enrollment
69 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer